Market Closed -
London S.E.
09:05:08 26/04/2024 pm IST
|
5-day change
|
1st Jan Change
|
185.8
GBX
|
-0.43%
|
|
+1.20%
|
-10.46%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
587.1
|
636.1
|
523.4
|
730.3
|
561.5
|
403.8
|
403.8
|
-
|
Enterprise Value (EV)
1 |
510.7
|
571.3
|
480.7
|
667.2
|
489
|
390.8
|
416.1
|
412.8
|
P/E ratio
|
26.2
x
|
33.9
x
|
61.7
x
|
42.2
x
|
27.8
x
|
28.6
x
|
40.9
x
|
22.9
x
|
Yield
|
0.48%
|
0.52%
|
0.7%
|
0.58%
|
0.83%
|
1.14%
|
1.41%
|
1.6%
|
Capitalization / Revenue
|
5.72
x
|
6.21
x
|
6.03
x
|
6.72
x
|
4.52
x
|
3.57
x
|
2.26
x
|
1.74
x
|
EV / Revenue
|
4.98
x
|
5.58
x
|
5.54
x
|
6.14
x
|
3.93
x
|
3.1
x
|
2.33
x
|
1.78
x
|
EV / EBITDA
|
16.5
x
|
18.7
x
|
26.8
x
|
21.7
x
|
14.6
x
|
13.2
x
|
11.1
x
|
8.5
x
|
EV / FCF
|
29.5
x
|
30
x
|
25.1
x
|
22.8
x
|
21.1
x
|
44.4
x
|
-26.3
x
|
13.7
x
|
FCF Yield
|
3.39%
|
3.33%
|
3.99%
|
4.38%
|
4.73%
|
2.25%
|
-3.81%
|
7.32%
|
Price to Book
|
3.39
x
|
3.32
x
|
2.62
x
|
3.48
x
|
2.4
x
|
1.86
x
|
1.61
x
|
1.54
x
|
Nbr of stocks (in thousands)
|
2,13,479
|
2,14,891
|
2,15,384
|
2,16,071
|
2,16,793
|
2,17,341
|
2,17,341
|
-
|
Reference price
2 |
2.750
|
2.960
|
2.430
|
3.380
|
2.590
|
1.858
|
1.858
|
1.858
|
Announcement Date
|
13/03/19
|
11/03/20
|
17/03/21
|
16/03/22
|
15/03/23
|
13/03/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
102.6
|
102.4
|
86.8
|
108.6
|
124.3
|
126.2
|
178.3
|
231.8
|
EBITDA
1 |
30.86
|
30.62
|
17.92
|
30.79
|
33.48
|
29.68
|
37.34
|
48.56
|
EBIT
1 |
28.7
|
27.46
|
14.45
|
26.9
|
29.43
|
25.3
|
27.44
|
37.72
|
Operating Margin
|
27.98%
|
26.83%
|
16.65%
|
24.77%
|
23.67%
|
20.05%
|
15.39%
|
16.27%
|
Earnings before Tax (EBT)
1 |
28.43
|
24.26
|
10.09
|
21.98
|
25.91
|
21.16
|
15.33
|
25.4
|
Net income
1 |
22.65
|
18.92
|
8.584
|
17.48
|
20.41
|
15.89
|
9.775
|
17.7
|
Net margin
|
22.08%
|
18.48%
|
9.89%
|
16.1%
|
16.41%
|
12.59%
|
5.48%
|
7.64%
|
EPS
2 |
0.1048
|
0.0872
|
0.0394
|
0.0801
|
0.0930
|
0.0725
|
0.0454
|
0.0810
|
Free Cash Flow
1 |
17.34
|
19.03
|
19.16
|
29.26
|
23.14
|
8.801
|
-15.85
|
30.21
|
FCF margin
|
16.9%
|
18.59%
|
22.08%
|
26.94%
|
18.61%
|
6.97%
|
-8.89%
|
13.03%
|
FCF Conversion (EBITDA)
|
56.18%
|
62.14%
|
106.96%
|
95.02%
|
69.1%
|
29.66%
|
-
|
62.21%
|
FCF Conversion (Net income)
|
76.54%
|
100.57%
|
223.26%
|
167.36%
|
113.39%
|
55.39%
|
-
|
170.69%
|
Dividend per Share
2 |
0.0132
|
0.0155
|
0.0170
|
0.0195
|
0.0215
|
0.0236
|
0.0262
|
0.0297
|
Announcement Date
|
13/03/19
|
11/03/20
|
17/03/21
|
16/03/22
|
15/03/23
|
13/03/24
|
-
|
-
|
Fiscal Period: December |
2019 S1
|
2019 S2
|
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2023 S1
|
2023 S2
|
---|
Net sales
1 |
48.71
|
-
|
39.28
|
-
|
-
|
58.4
|
58.3
|
63.09
|
63.12
|
EBITDA
|
13.67
|
-
|
-
|
-
|
-
|
15.86
|
-
|
23.85
|
14.21
|
EBIT
1 |
-
|
-
|
5.5
|
-
|
-
|
13.91
|
12.24
|
13.43
|
11.88
|
Operating Margin
|
-
|
-
|
14%
|
-
|
-
|
23.82%
|
20.99%
|
21.28%
|
18.81%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-
|
10.79
|
-
|
11.77
|
9.389
|
Net income
|
-
|
-
|
-
|
-
|
8.932
|
8.549
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
14.64%
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
0.0410
|
0.0391
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.0105
|
-
|
0.0120
|
-
|
0.0137
|
-
|
0.007000
|
0.0166
|
Announcement Date
|
11/09/19
|
11/03/20
|
16/09/20
|
17/03/21
|
15/09/21
|
16/03/22
|
14/09/22
|
20/09/23
|
13/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
12.3
|
8.95
|
Net Cash position
1 |
76.4
|
64.8
|
42.7
|
63.1
|
72.5
|
60.2
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
0.3296
x
|
0.1843
x
|
Free Cash Flow
1 |
17.3
|
19
|
19.2
|
29.3
|
23.1
|
8.8
|
-15.8
|
30.2
|
ROE (net income / shareholders' equity)
|
13.9%
|
10.4%
|
4.36%
|
8.43%
|
9.08%
|
8.56%
|
9.6%
|
11%
|
ROA (Net income/ Total Assets)
|
12.4%
|
8.75%
|
3.69%
|
7.16%
|
7.69%
|
5.57%
|
-
|
-
|
Assets
1 |
182.1
|
216.1
|
232.8
|
244
|
265.3
|
285.1
|
-
|
-
|
Book Value Per Share
2 |
0.8100
|
0.8900
|
0.9300
|
0.9700
|
1.080
|
1.110
|
1.150
|
1.210
|
Cash Flow per Share
2 |
0.0900
|
0.1000
|
0.1000
|
0.1400
|
0.1200
|
0.0600
|
0.1300
|
0.1800
|
Capex
1 |
3.06
|
2.67
|
2.35
|
1.77
|
3.74
|
3.54
|
5.33
|
5
|
Capex / Sales
|
2.98%
|
2.61%
|
2.7%
|
1.63%
|
3.01%
|
2.81%
|
2.99%
|
2.16%
|
Announcement Date
|
13/03/19
|
11/03/20
|
17/03/21
|
16/03/22
|
15/03/23
|
13/03/24
|
-
|
-
|
Last Close Price
1.858
GBP Average target price
2.522
GBP Spread / Average Target +35.75% Consensus |
1st Jan change
|
Capi.
|
---|
| -10.46% | 503M | | +11.84% | 27.79B | | -32.98% | 2.98B | | -15.97% | 2.52B | | +11.90% | 2.34B | | -1.11% | 1.91B | | -7.78% | 1.39B | | -0.38% | 1.27B | | +4.01% | 1.13B | | +13.51% | 1.12B |
Medical Supplies
|